Olaparib combined with immunotherapy for treating a patient with liver cancer carrying BRCA2 germline mutation: A case report

por Zhao, Fengjiao, Zhou, Yong, Seesaha, Poshita Kumari, Zhang, Yihong, Liu, Siqin, Gan, Xiaoyan, Hu, Jun, Gu, Yanhong, Chen, Xiaofeng
Publicado 2020

Case fatality rate of the adult in-patients with COVID-19 and digestive system tumors: A systematic review and meta-analysis

por Wang, Guoqun, Pan, Lanlan, Zhao, Jianyi, Tang, Jie, Fang, Yueyu, Sun, Hui, Seesaha, Poshita Kumari, Chen, Wensen, Chen, Xiaofeng
Publicado 2022

Current Progress and Future Perspectives of Immune Checkpoint Inhibitors in Biliary Tract Cancer

por Seesaha, Poshita-Kumari, Wang, Kang-Xin, Wang, Guo-Qun, Cui, Ting-Yun, Zhao, Feng-Jiao, Pan, Lan-Lan, Li, Xiang-Cheng, Shu, Yong-Qian, Chen, Xiao-Feng
Publicado 2021

Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial

por Chen, Xiaofeng, Wu, Xiaofeng, Wu, Hao, Gu, Yanhong, Shao, Yang, Shao, Qianwen, Zhu, Feipeng, Li, Xiao, Qian, Xiaofeng, Hu, Jun, Zhao, Fengjiao, Mao, Weidong, Sun, Jing, Wang, Jian, Han, Gaohua, Li, Changxian, Xia, Yongxiang, Seesaha, Poshita Kumari, Zhu, Dongqin, Li, Huajun, Zhang, Junling, Wang, Guoqiang, Wang, Xuehao, Li, Xiangcheng, Shu, Yongqian
Publicado 2020